Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.

Abstract

British Journal of Clinical PharmacologyVolume 10, Issue S1 p. 157S-164S Free Access Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine. P. Jerie, P. JerieSearch for more papers by this author P. Jerie, P. JerieSearch for more papers by this author First published: February 1980 https://doi.org/10.1111/j.1365-2125.1980.tb04924.xCitations: 22AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References AMERY, A.K.P.C., BOSSAERT, H., FAGARD, R.H. & VERSTRAETE, M. (1972). Clonidine versus Methyldopa: A double blind cross-over study comparing side effects of clonidine and methyldopa administered together with chlorthalidone at a dosage producing the same blood pressure lowering effect. Acta Cardiol., 27, 82– 99. ARNOLD, O.H. (1971). Die medikamentöse Therapie der arteriellen Hypertonie. Internistische Praxis, 11, 451– 455. BEVAN, A., HONOUR, A.J. & STOTT, F.G. (1966). Portable recorder for continuous arterial pressure measurement in man. J. Physiol. Lond., 186, 3P. BULPITT, C.J. & DOLLERY, C.T. (1973). Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br. med. J., 3, 485– 490. DOLLERY, C.T. (1976). Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy. Aust. N.Z.J., 6, suppl. 3, 88– 94. DUKES, M.N.G. (1977). Side-effects of Drugs. Annual I pp. v– ix. Amsterdam and Oxford: Excerpta Medica. ESCH, I. (1976). Erste Erfahrungen mit BS 100–141, einer neuen blutdrucksenkenden Substanz. Int. J. clin. Pharmac., 14, 109– 112. GEYSKES, G.G., BOER, P. & DORHOUT MEES, E.J. (1979). Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br. J. clin. Pharmac., 7, 55– 62. GOLDBERG, A.D., WILKINSON, P.R. & RAFTERY, E.B. (1976). The over-shoot phenomenon on withdrawal of clonidine therapy. Postgrad. med. J., 52, suppl. 7, 128– 134. GOLDBERG, A.D., RAFTERY, E.B. & WILKINSON, P. (1977). Blood pressure and heart rate and withdrawal of antihypertensive drugs. Br. med. J., 1, 1243– 1246. HANSSON, L., HUNYOR, S.N., JULIUS, S. & HOOBLER, S.W. (1973). Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am. Heart J., 85, 605– 610. JÄÄTTELÄ, A. (1976a). Clinical efficacy of BS 100–141 in essential hypertension: A single-blind pilot study. Eur. J. clin. Pharmac., 10, 69– 72. JÄÄTTELÄ, A. (1976b). Comparison of BS 100–141 and clonidine as antihypertensive agents. Eur. J. clin. Pharmac., 10, 73– 76. JERIE, P. (1980). Guanfacine in long-term treatment of hypertension: Part I: Efficacy and dosage. Br. J. clin. Pharmac., 10, 37– 48S. KIRCH, W. & DISTLER, A. (1978). Anthypertensive effect of N-amidino-2-(2, 6-dichlorophenyl) acetamide hydrochloride: A double-blind cross-over trial versus clonidine. Int. J. clin. Pharmac., 16, 132– 135. McMAHON, F.G. (1978). Management of Essential Hypertension. Mount Kisco, New York: Futura Publishing Company. MANHEM, P. & HÖKFELT, B. (1980). Effect of guanfacine on blood pressure, pulse rate, catecholamines and plasma renin activity in moderate hypertension. Br. J. clin. Pharmac., 10, 109– 114S. MROCZEK, W.J. & DAVIDOV, M.E. (1978). Rebound hypertension after withdrawal of antihypertensive therapy. Clin. Res., 26, 622. PARSONS, W.B. & MORLEDGE, J.H. (1970). Antihypertensive effect of a new imidazoline compound (clonidine) and chlorthalidone, individually and in combination. Am. J. Cardiol., 26, 258– 261. REID, J.L. (1977). Clonidine withdrawal in hypertension: Changes in blood pressure and plasma and urinary noradrenaline. Lancet, i, 1171– 1174. REID, J.L. & ZAMBOULIS, C. (1980). Guanfacine: effects of long term treatment and withdrawal. Br. J. clin. Pharmac., 10, 183– 188S. RÖCKEL, A., SABEL, B. & HEIDLAND, A. (1978). Therapie der essentiellen und renalen Hypertonien mit BS 100–141 (Guanfacinum). Herz/Kreislauf, 10, 136– 142. SEEDAT, Y.K. (1978). Long-term treatment of hypertension with guanfacine (BS 100–141) alone and in combination therapy, Curr. ther. Res., 24, 288– 298. SPACH, M.O., STEIMER, C. & BLOCH, R. (1977). Manifestations cliniques à l'arrêt d'un traitement prolongé par la clonidine. Nouv. Presse méd., 6, 1201– 1205. VETERANS ADMINISTRATION COOPERATIVE GROUP ON ANTIHYPERTENSIVE AGENTS. (1967). Effects of treatment on morbidity in hypertension, I. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. J. Am. med. Assoc., 202, 116– 122. WHITSETT, Th.L., CHRYSANT, S.G., DILLARD, B.L. & ANTON, A.H. (1978). Abrupt cessation of clonidine administration: A prospective study. Am. J. Cardiol., 41, 1285– 1290. Citing Literature Volume10, IssueS1February 1980Pages 157S-164S ReferencesRelatedInformation